Proceedings.

Analysis · Case update

Asbestos Corporation: the NSI trustee wants the law decided before the protocol

The chapter 7 trustee of National Service Industries, with a proof of claim for about US$151 million, asks the Québec court, not the monitor, to decide which law governs the asbestos claims against ACL and whether ACL is a manufacturer under the Civil Code, and to order ACL to produce documents. The application, dated November 16, is returnable December 9.

Proceedings. · · 10 min read

The chapter 7 trustee of the estate of National Service Industries, Inc. filed a proof of claim against Asbestos Corporation Limited for about US$151 million before the September 10 bar date, according to an application dated November 16, 2026. In it the NSI trustee asks the Superior Court of Québec to decide, before the monitor's claims protocol is developed and approved, which law governs the asbestos claims against ACL, whether ACL is a manufacturer under the Civil Code, what claimants must prove and what defences ACL may raise; and to order ACL to produce documents and name a representative to be examined, per the NSI Trustee's Application, Nov. 16, 2026, paras. 1, 19. Its notice of presentation sets it down before the Commercial Division at the Québec City courthouse on December 9, 2026, per the Notice of Presentation, p. 36.

Some of the records the application says claimants cannot reach are ACL's own annual reports. Those for 1944, 1947 to 1953, 1956 to 1958 and 1960 to 1977, it says, exist only on paper, in a box in McGill University's archives. When the trustee's counsel tried to consult the archives, the application says, "an exposure to disintegrating asbestos occurred: the cover of one of ACL's annual reports was literally made of asbestos paper, which contaminated the entire archive box" [translation]. McGill's staff stopped the consultation, it says, and the university has since judged the box too dangerous to consult; the application cites an email from McGill of November 11, 2026. Until the box is fully decontaminated, it says, the reports cannot be read, per the Application, paras. 69–71.

When this case was last reported here, on November 10, the Court of Appeal had refused the U.S. law firms leave to appeal the September 9 judgment on their standing.

"Under applicable law"

The asbestos claims review and adjudication order of June 19, 2026 describes the monitor's task in its Schedule B: "The Monitor will assess whether the Claim is eligible for compensation under applicable law, evaluating the legal elements of the Claim and ACL's defenses thereto …" The valuation matrix was taken out of that order, and Justice Jean-François Émond wrote that ACL and CLMI "will supplement the Asbestos Claims Review and Adjudication Order with a protocol that will be submitted to the Court for approval," per the Judgment of June 19, 2026 (certified translation), paras. 40–41 & Sch. B, p. 37. The application puts the hearing on the protocol at February 16 to 18, 2027, and says the applicable law and the elements of ACL's liability "must henceforth be dealt with in the Protocol" [translation], per the Application, paras. 13, 81.

The application objects to that order of steps. Claimants had to file detailed proofs of claim by September 10, it says, "although no order was made at the same time specifying under what law and standards their claims will be assessed" [translation], and the form did not ask them to show ACL's fault, per the Application, paras. 4, 58. It argues that no earlier CCAA proceeding has dealt with liability claims of comparable complexity. In the earlier mass-tort cases, it says, the link was direct: a tobacco illness to the brand smoked, a railway accident to the company that owned the train, contaminated blood to the organization that supplied it, abuse by clergy to the Church that employed them. ACL, the application says, sold its fibre to other manufacturers, among them, according to the monitor's historical sales summaries, National Gypsum, Fibreboard, Eagle-Picher Industries and H.K. Porter, so that establishing its liability means reconstructing, "link by link, the supply chain connecting ACL's fibre to the product(s) to which the victim was exposed" [translation], per the Application, paras. 8, 29–30, 44–45.

Seven questions

The application calls them the preliminary questions: whether the law governing the merits is the tort law of the U.S. state where the harm-causing event occurred, or of the state where suit was brought, or Québec law; when the exposures to ACL's fibre took place, and in particular whether before the Civil Code of Québec came into force; if Québec law applies, whether the Civil Code of Québec or the Civil Code of Lower Canada of 1865 governs; whether ACL is a manufacturer within article 1468 C.c.Q.; whether, on those answers, the manufacturer's presumption of fault applies; which elements of ACL's liability claimants must prove; and ACL's defences, including its knowledge of the health risks, the sufficiency of its warnings and prescription, per the Application, para. 13. Paragraph 121, to which the conclusions refer, adds whether filing a proof of claim interrupted prescription, per para. 121.

Article 3129 C.c.Q., the application says, is the rule on which the monitor's position rests, and it came into force in the form of article 8.1 of the Civil Code of Lower Canada only on June 22, 1989, "after almost the whole of the period in which ACL marketed asbestos" [translation]. Under the transitional law, it says, civil liability is governed by the law in force when the fault was committed, so ACL's liability "would therefore potentially be governed, for the most part, by article 1053 C.c.B.C. …" [translation], per the Application, para. 93. The manufacturer question, on the application's account, decides the burden. If Québec law applies and ACL is a manufacturer, it says, a claimant who proves the safety defect has a presumption against ACL, which can escape it only by a defence under article 1473; if not, each claimant must prove ACL's fault under article 1457, "including proof of its knowledge of the risks of asbestos and of its failure to warn adequately" [translation], per para. 97. For manufacturer status it cites Deguise c. Montminy, 2014 QCCS 2672, as holding that a quarry that extracts, crushes, sorts and grades stone by quality is a manufacturer, and quotes ACL's 1978 annual report on its "three complete primary and secondary finishing mills, together with four integrated ore preparation and storage plants" at Thetford Mines, per the Application, paras. 95–96.

Positions already taken, by the application's account

The application says the monitor and the co-applicants have answered some of these questions piecemeal. On July 14, 2026, it says, the monitor, through its counsel and in answer to questions from the trustee's counsel, announced that "Québec law will govern the determination of claims against ACL," referring to article 3129 C.c.Q., and the same exchange said the monitor "will consider any valid defence that would have been available to ACL," including causation, apportionment, contributory fault, prescription and insufficient proof. At the hearing of October 20 and 21, 2026, by the application's account, the monitor and the co-applicants argued that ACL is not a manufacturer within article 1468, and the co-applicants have said at an earlier hearing that they will plead prescription, per the Application, paras. 88, 91. It calls oversimplified a line in a FAQ it says the monitor published on its website: "ACL is a Québec-based company that extracted and sold asbestos in the past," per the Monitor's FAQ, p. 1 and the Application, para. 91(b). It also cites Justice Suzanne Gagné of the Court of Appeal, who wrote on October 3, 2025 that the proceedings the applicants for leave wanted to pursue in the United States "are not based on Quebec law. The handling of potential claims will raise complex questions of private international law (Articles 3129 and 3151 C.C.Q.)," per the Court of Appeal judgment of Oct. 3, 2025 (certified translation), para. 16 and the Application, para. 86.

Keep reading with a 5-day free trial

About 5 more minutes of this analysis, and 1 more section. Every fact in it cites the filing it was read from.

Start 5-day trial

Card required. Nothing charged for 5 days. Cancel anytime.

Already a subscriber? Sign in.

See all plans⁠

Analysis is editorial; every factual claim cites the record. The record itself never editorializes.

Facts and summaries are extracted automatically from the court filings linked on each page; the filings remain the authoritative record. Suggested corrections are reviewed against the source filings.